MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

MDS Virtual Congress 2020

September 12-16, 2020. Virtual Congress. www.mdscongress.org

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • The effect of exercise on pain in Parkinson’s disease: A protocol for a systematic review

    V. Nguy, L. Hassett, C. Canning, J. Elliott, N. Allen (Sydney, Australia)

  • The effect of levodopa and cognitive-motor dual interference on gait parameters in PD FOG

    J. Longhurst, J. Rider, B. Bluett, M. Landers (Las Vegas, NV, USA)

  • The Effect of Rasagiline on Motor and Non-Motor Symptoms in Parkinson’s Disease

    B.G Koçer, E.A Özturk, SS. Çomoğlu (Ankara, Turkey)

  • The effect of severity of Parkinson’s disease on chronic headache

    J.Y Ahn, H.T Kim (Seoul, Republic of Korea)

  • The Efficacy of Teleconsultation for Management of Movement Disorders in Thailand

    W. Phuenpathom, P. Jagota, R. Bhidayasiri (Bangkok, Thailand)

  • The efficacy of traditional Mikkyo Buddhism meditation in stress management of Parkinson’s syndrome patients

    S. Murahashi, Y. Takeuchi, Y. Hara (Yatsushiro, Japan)

  • The exosomal a-syn filaments can be a novel biomarker of Parkinson’s disease

    Y. Ishiguro, T. Tsunemi, A. Yoroisaka, N. Hattori (Tokyo, Japan)

  • The feasibility of cognitive telerehabilitation in patients with Parkinson´s disease: The pilot data

    V. Plzáková (Prague, Czech Republic)

  • The feasibility of detailed phenotyping of muscle mitochondrial respiratory chain function and content in Parkinson’s disease

    A. Yarnall, A. Granic, S. Waite, K. Hollingsworth, C. Warren, A. Vincent, G. Gorman, D. Turnbull, R. Taylor, R. Dodds, A. Sayer (Newcastle upon Tyne, United Kingdom)

  • The Feasibility of Using of the Non-Medication in the Treatment of Post-Stroke Vascular Parkinsonism

    O. Tondiy, O. Zavalna (Kharkiv, Ukraine)

  • « Previous Page
  • 1
  • …
  • 131
  • 132
  • 133
  • 134
  • 135
  • …
  • 149
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley